Skip to main content
Clinical Trials/NCT01759693
NCT01759693
Unknown
Not Applicable

Platelet Activation in Chronic Inflammatory Skin Diseases

Meir Medical Center1 site in 1 country80 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urticaria
Sponsor
Meir Medical Center
Enrollment
80
Locations
1
Primary Endpoint
Platelet activation
Last Updated
13 years ago

Overview

Brief Summary

Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
October 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Urticaria or atopic dermatitis -

Exclusion Criteria

  • Lack of informed consent

Outcomes

Primary Outcomes

Platelet activation

Time Frame: 6 months

Platelet function will be assessed at enrollment

Secondary Outcomes

  • Mean platelet volume(6 months)

Study Sites (1)

Loading locations...

Similar Trials